Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medication-induced peripheral neuropathy.

Louis H Weimer1

  • 1Neurological Institute of New York, 710 West 168th Street, Unit 55, New York, NY 10032, USA. Lhw1@columbia.edu

Current Neurology and Neuroscience Reports
|January 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophy.

Brain : a journal of neurology·2025
Same author

Biallelic Loss-of-Function Variants in <i>BICD1</i> Are Associated with Peripheral Neuropathy and Hearing Loss.

International journal of molecular sciences·2023
Same author

Lack of effect on ambulation of dalfampridine-ER (4-AP) treatment in adult SMA patients.

Neuromuscular disorders : NMD·2020
Same author

Neuromuscular disorders in pregnancy.

Handbook of clinical neurology·2020
Same author

Peripheral neuropathy symptoms in wild type transthyretin amyloidosis.

Journal of the peripheral nervous system : JPNS·2020
Same author

Update on Chemotherapy-Induced Peripheral Neuropathy.

Current neurology and neuroscience reports·2017
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026
Same journal

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

Current neurology and neuroscience reports·2026
Same journal

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Current neurology and neuroscience reports·2026
Same journal

Assessment and Management of Post-traumatic Headache.

Current neurology and neuroscience reports·2026
See all related articles

Medication-induced neuropathy, though uncommon, is treatable and important to identify. Ongoing research seeks to prevent or reduce toxic neuropathy from essential medications.

Area of Science:

  • Neurology
  • Toxicology

Background:

  • Medication-induced neuropathy is an increasingly relevant concern for neurologists due to expanding medication use.
  • Essential treatments for conditions like HIV and malignancy can cause toxic neuropathies.
  • Identifying at-risk patients, potentially due to genetic factors or pre-existing neuropathies, is crucial.

Purpose of the Study:

  • To highlight the significance of identifying and managing medication-induced neuropathy.
  • To discuss the challenges and ongoing research in preventing or ameliorating drug-induced nerve toxicity.
  • To explore potential future advancements in drug delivery and understanding underlying mechanisms.

Main Methods:

  • Review of current literature on medication-induced neuropathy.
  • Discussion of pathomechanisms, including apoptosis.

Related Experiment Videos

  • Consideration of risk factors and emerging causes.

    • Main Results:

    • Medication-induced neuropathy is a treatable condition requiring identification.
    • Apoptosis is an emerging pathway in toxic neuropathy.
    • Statins may represent an occult cause of chronic idiopathic neuropathy.

    Conclusions:

    • Early identification and management of medication-induced neuropathy are essential.
    • Further research is needed to develop strategies for preventing or treating drug toxicities.
    • Understanding the pathomechanisms may lead to safer therapeutic strategies.